Anthem Blue Cross and Blue Shield Parent Company to Acquire Indiana University Health Plans
Indiana University Health has entered into an agreement for Elevance Health to buy Indiana University Health Plans Medicare Advantage and Commercial at the end of 2024. Additional information is available in the press release.
If you are an IU Health Plans Medicare Advantage member, your plan coverage will remain unchanged for the rest of 2024. If you take no action, you will continue with the same plan next year. As the 2025 Medicare Annual Enrollment Period approaches, we will provide detailed information about your options, allowing you to explore them with your broker and choose the best fit for your needs.
If you have questions, please call 800.455.9776 (TTY/TDD 711) 8 am – 8 pm, Monday – Friday. Language assistance is available.
H7220_IUHS03_C
If you are an IU Health Plans Commercial member, there will be no changes to your IU Health Plans healthcare coverage for the remainder of 2024. As we approach 2025, we will communicate any updates pertaining to your health plan.
If you have questions, please call 800.895.5828 (TTY/TDD 711) 7 am – 7 pm, Monday – Friday. Language assistance is available.
Anthem Blue Cross and Blue Shield Parent Company to Acquire Indiana University Health Plans
Indiana University Health has entered into an agreement for Elevance Health to buy Indiana University Health Plans Medicare Advantage and Commercial at the end of 2024. Additional information is available in the press release.
If you are an IU Health Plans Medicare Advantage member, your plan coverage will remain unchanged for the rest of 2024. If you take no action, you will continue with the same plan next year. As the 2025 Medicare Annual Enrollment Period approaches, we will provide detailed information about your options, allowing you to explore them with your broker and choose the best fit for your needs.
If you have questions, please call 800.455.9776 (TTY/TDD 711) 8 am – 8 pm, Monday – Friday. Language assistance is available.
H7220_IUHS03_C
If you are an IU Health Plans Commercial member, there will be no changes to your IU Health Plans healthcare coverage for the remainder of 2024. As we approach 2025, we will communicate any updates pertaining to your health plan.
If you have questions, please call 800.895.5828 (TTY/TDD 711) 7 am – 7 pm, Monday – Friday. Language assistance is available.
Thank you for visiting the IU Health Plans website, we value your opinion on how we can improve your online experience. After you complete your visit, would you be willing to answer a few questions to help us improve our website? Please complete this survey after you have completed your online session.
Yes Maybe Later NeverIn the interest of our members’ health and safety, IU Health Plans monitors alerts from the Food and Drug Administration (FDA) regarding prescription drug recalls and withdrawals. Drugs may be recalled by the FDA or withdrawn from the market by a manufacturer for a variety of reasons including safety and efficacy. IU Health Plans identifies and notifies members that may be potentially impacted when a prescription drug is recalled or withdrawn. In addition to these notifications, updates will be provided on this webpage for easy access for our members and providers.
The FDA classifies recalls according to the potential consequences the drug may cause. The FDA defines these classifications as follows:
Class I: Dangerous or defective products (including drugs) that predictably could cause serious health problems or death. Examples include: a label mix-up on a lifesaving drug
Class II: Products (including drugs) that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.
A drug manufacturer may call a voluntary market withdrawal to remove or correct a marketed drug that the FDA may consider to be in violation of FDA laws.
If you receive a notice that your medications may be impacted by a drug recall please act upon the notice and follow up with your prescriber and/or pharmacy as instructed. If you have additional questions about your prescription drug benefits please contact us.
Click here for an archive of previous prescription drug recalls.
Indomethacin/Naproxen 11.27.23
Metoprolol 01.20.23
Allopurinol 01.20.23
Ferrous Sulfate 01.19.23
Rifampin 01.18.23
Multiple Akorn Inc. Products 01.14.23
Rifampin 01.09.23